ENTRY       D05255            Mixture   Drug
NAME        Omega-3-acid ethyl esters (USP);
            Omacor (TN)
PRODUCT
  GENERIC   LOVAZA (Woodward Pharma Services LLC)
            OMEGA-3-ACID ETHYL ESTER (Bionpharma)
            OMEGA-3-ACID ETHYL ESTER (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (A-S Medication Solutions)
            OMEGA-3-ACID ETHYL ESTERS (A-S Medication Solutions)
            OMEGA-3-ACID ETHYL ESTERS (American Health Packaging)
            OMEGA-3-ACID ETHYL ESTERS (Amneal Pharmaceuticals LLC)
            OMEGA-3-ACID ETHYL ESTERS (Apotex Corp.)
            OMEGA-3-ACID ETHYL ESTERS (AvKARE)
            OMEGA-3-ACID ETHYL ESTERS (AvPAK)
            OMEGA-3-ACID ETHYL ESTERS (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (Bryant Ranch Prepack)
            OMEGA-3-ACID ETHYL ESTERS (Camber Pharmaceuticals)
            OMEGA-3-ACID ETHYL ESTERS (EPIC PHARMA)
            OMEGA-3-ACID ETHYL ESTERS (Lifestar Pharma LLC)
            OMEGA-3-ACID ETHYL ESTERS (Major Pharmaceuticals)
            OMEGA-3-ACID ETHYL ESTERS (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
            OMEGA-3-ACID ETHYL ESTERS (Par Pharmaceutical)
            OMEGA-3-ACID ETHYL ESTERS (REMEDYREPACK)
            OMEGA-3-ACID ETHYL ESTERS (Strides Pharma Science Limited)
            OMEGA-3-ACID ETHYL ESTERS (XLCare Pharmaceuticals)
COMPONENT   Ethyl icosapentate [DR:D01892], Ethyl docosahexaenoate [CPD:C16185]
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
REMARK      Therapeutic category: 2189
            ATC code: C10AX06
            Product: D05255<JP/US>
EFFICACY    Antihyperlipidemic, Triglyceride synthesis inhibitor, Lipoprotein lipase (LPL) activator, Cholesteryl ester transfer protein inhibitor
  DISEASE   Hypertriglyceridemia [DS:H01637]
TARGET      LPL [HSA:4023] [KO:K01059]
            CETP [HSA:1071] [KO:K16835]
  PATHWAY   hsa00561(4023)  Glycerolipid metabolism
            hsa03320(4023)  PPAR signaling pathway
            hsa04979(1071+4023)  Cholesterol metabolism
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AX Other lipid modifying agents
                 C10AX06 Omega-3-triglycerides incl. other esters and acids
                  D05255  Omega-3-acid ethyl esters (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, Other
               Omega-3-acid Ethyl Esters
                D05255  Omega-3-acid ethyl esters (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               218  Hyperlipidemia agents
                2189  Others
                 D05255  Omega-3-acid ethyl esters (USP)
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               D05255  Omega-3-acid ethyl esters
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01946  Hypolipidemic agent
               D05255  Omega-3-acid ethyl esters
            Target-based classification of drugs [BR:br08310]
             Transporters
              Other transporters
               Channels and pores (TC:1)
                CETP
                 D05255  Omega-3-acid ethyl esters (USP) &lt;JP/US&gt;
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                LPL
                 D05255  Omega-3-acid ethyl esters (USP) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05255
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05255
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05255
DBLINKS     PubChem: 47206969
///
